ArticleInflammopharmacology2021

Bevacizumab regulates inflammatory cytokines and inhibits VEGFR2 signaling pathway in an ovalbumin-induced rat model of airway hypersensitivity.

Seyed Mohammadreza Bolandi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.